深度学习评估结直肠癌肿瘤纯度及其对分子分析的影响
该研究基于三个多中心结直肠癌队列(N=1,097),比较深度学习模型SoftCTM与传统病理评估及生物信息学反卷积法在肿瘤纯度估计(TPE)中的效用与准确性,并评估其对拷贝数变异(CNV)分析的影响。结果显示SoftCTM具有高重复性,与RNA表达和DNA甲基化相关性优于传统病理,且能调和分子数据高估与病理低估的偏差,减少CNV调用差异。
要点
- SoftCTM在相同切片重复应用时技术重复性r=1.0,配对H&E切片相关性r>0.9。
- SoftCTM估计与RNA表达(r=0.59)和DNA甲基化(r=0.40)相关性高于传统病理(r=0.41和0.29)。
- 传统病理和反卷积法分别低估和高估肿瘤含量,导致6-13%的CNV调用差异。
核心结论
- SoftCTM可实现单细胞分辨率下可重复、自动化、标准化的肿瘤纯度估计,为下游分子分析提供更可靠的中间值。
研究设计与样本
- 使用三个大型多中心结直肠癌队列(N=1,097例患者),包含数字病理和多组学数据,比较SoftCTM与传统病理及生物信息学反卷积方法(RNA表达、DNA甲基化)在肿瘤纯度估计及下游分子分析(包括CNV分析)中的效用和准确性。
主要发现
- SoftCTM在相同切片重复应用时技术重复性r=1.0,配对H&E切片相关性r>0.9。
- SoftCTM估计与RNA表达相关性r=0.59、与DNA甲基化相关性r=0.40;传统病理估计与RNA表达相关性r=0.41、与DNA甲基化相关性r=0.29。
- 传统病理和反卷积法分别低估和高估肿瘤含量,导致6-13%的CNV调用差异。
- SoftCTM估计均值58.9%(SD±16.3%),调和了分子数据外推的高估(RNA表达均值79.2%,SD±10.5;DNA甲基化均值62.7%,SD±11.8%)和传统病理的低估(均值35.9%,SD±13.1%)。
临床怎么用
- 全整合的计算病理解决方案可用于改善研究和临床中的下游分子分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tumour content plays a pivotal role in directing the bioinformatic analysis of molecular profiles such as copy number variation (CNV). In clinical application, tumour purity estimation (TPE) is achieved either through visual pathological review [conventional pathology (CP)] or the deconvolution of molecular data. While CP provides a direct measurement, it demonstrates modest reproducibility and lacks standardisation. Conversely, deconvolution methods offer an indirect assessment with uncertain accuracy, underscoring the necessity for innovative approaches. SoftCTM is an open-source, multiorgan deep-learning (DL) model for the detection of tumour and non-tumour cells in H&E-stained slides, developed within the Overlapped Cell on Tissue Dataset for Histopathology (OCELOT) Challenge 2023. Here, using three large multicentre colorectal cancer (CRC) cohorts (N = 1,097 patients) with digital pathology and multi-omic data, we compare the utility and accuracy of TPE with SoftCTM versus CP and bioinformatic deconvolution methods (RNA expression, DNA methylation) for downstream molecular analysis, including CNV profiling. SoftCTM showed technical repeatability when applied twice on the same slide (r = 1.0) and excellent correlations in paired H&E slides (r > 0.9). TPEs profiled by SoftCTM correlated highly with RNA expression (r = 0.59) and DNA methylation (r = 0.40), while TPEs by CP showed a lower correlation with RNA expression (r = 0.41) and DNA methylation (r = 0.29). We show that CP and deconvolution methods respectively underestimate and overestimate tumour content compared to SoftCTM, resulting in 6-13% differing CNV calls. In summary, TPE with SoftCTM enables reproducibility, automation, and standardisation at single-cell resolution. SoftCTM estimates (M = 58.9%, SD ±16.3%) reconcile the overestimation by molecular data extrapolation (RNA expression: M = 79.2%, SD ±10.5, DNA methylation: M = 62.7%, SD ±11.8%) and underestimation by CP (M = 35.9%, SD ±13.1%), providing a more reliable middle ground. A fully integrated computational pathology solution could therefore be used to improve downstream molecular analyses for research and clinics. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
引用
- Schoenpflug LA, Chatzipli A, Sirinukunwattana K, et al. Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis. J Pathol. 2024. PMID: 39710952. doi:10.1002/path.6376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。